ENDRA Life Sciences Inc.
NDRA
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imā¦ read more
Healthcare
Diagnostics & Research
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$4.26
Price-5.96%
-$0.27
1Y
Price
Market Cap
$3.206m
Small
Price/Earnings 3y Avg5y Avg
0.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$0.00
-
1y CAGR-
3y CAGR-
5y CAGREarnings
-$8.007m
+30.4%
1y CAGR+13.2%
3y CAGR+5.6%
5y CAGREPS
-$13.40
-30.7%
1y CAGR-30.3%
3y CAGR-29.0%
5y CAGRBook Value
$171.380k
$1.964m
Assets$1.793m
Liabilities$525.330k
DebtDebt to Assets
26.8%
-0.1x
Debt to EBITDAFree Cash Flow
-$5.104m
+31.2%
1y CAGR+26.6%
3y CAGR+15.9%
5y CAGRNo items found.
Press Releases
Statements and updates from the company